Open AccessInitial clinical experience of ranibizumab therapy for neovascular age-related macular degeneration
Author(s) -
Tryfon Rotsos,
Patel
Publication year - 2010
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s14684
Subject(s) - medicine , ranibizumab , macular degeneration , visual acuity , ophthalmology , retrospective cohort study , adverse effect , cohort , pro re nata , optometry , surgery , bevacizumab , chemotherapy
To describe the visual acuity and safety outcomes for the first 50 patients with neovascular age-related macular degeneration (nAMD) treated with ranibizumab at Moorfields Eye Hospital.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom